A case of extremely advanced prostate cancer presenting hemolytic jaundice.
A 62-year-old man having prostate cancer presenting with hemolytic jaundice is reported. The hemolytic jaundice was cured by diethylstilbestrol diphosphate (DES-P) treatment, but the patient died one year and two months later from relapse of prostate cancer. An autopsy confirmed the diagnosis of prostate cancer with multiple metastases. Sudden anemia caused by bone metastasis might have caused the hemolytic jaundice. DES-P cured bone metastasis and then improved anemia when associated with transfusion. Consequently, hemolytic jaundice was cured.
Wakisaka
M
M
Department of Urology, Social Insurance Funabashi Chu-Oh Hospital.
Takagishi
H
H
D000230:Adenocarcinoma / Q000150:complications* / Q000556:secondary; D000743:Anemia, Hemolytic / Q000209:etiology*; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000150:complications* / Q000473:pathology